Brief: Biostage says provides regulatory update of Cellspan Esophageal Implant

Harvard Apparatus Regenerative Technology

06/10/2016 21:09

Oct 6 (Reuters) - Biostage Inc  BSTG.O  
    * Biostage management has determined that it will extend 
duration of ongoing GLP animal studies 
    * Biostage provides regulatory update of Cellspan Esophageal 
Implant 
    * Expects to file its ind application with FDA by end of Q2 
of 2017 
    * FDA requested that company extend its pre-clinical 
large-animal safety study for its Cellspan Esophageal Implant 
 
Source text for Eikon:  ID:nPn9zvtrha  
Further company coverage:  BSTG.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))